31/05 2024 Regulatory The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of MSEK 7,5. The Board of Directors in Redsense Medical AB (publ) ("Redsense" or the "Company") announces today that the Company’s Board of Directors, with the support from… [read more]
27/05 2024 Regulatory The CEO leaves Redsense Medical AB The Board of Directors of Redsense Medical AB and Pontus Nobréus, CEO since Aug 2022, have reached a mutual agreement that Pontus Nobréus will leave… [read more]
23/05 2024 Regulatory Major shareholding notification Redsense Medical AB hereby announces that ShapeQ GmbH has passed the disclosure threshold of 10 percent shareholding. Through a recent share purchase, ShapeQ GmbH has… [read more]